drugset / Trial / NCT00042328

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

NCT00042328

Phase 2 Completed 30 enrolled Baylor College of Medicine
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.

Timeline

Start
2001-08
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown Oral

Indications